The aim of this Research Training Program is to recruit and prepare highly qualified physician/scientists for an academic research career in medical or gynecological oncology by developing research skills in cancer biology and therapy. The general areas of training include: 1) Clinical Hematopoietic Cell Transplantation;2) Immunology and Vaccine Development;3) Transplantation Biology;4) Stem/Progenitor Cell Biology;5) Women's Cancer Research;6) Genito-urinary Cancer Research;7) Gastro-intestinal Cancer Research;8) Human Biology. All trainees will be members of the Hematology/Oncology or Gynecologic Oncology Fellowship Programs of the University of Washington/Fred Hutchinson Cancer Research Center. Trainees receive specific didactic training in the fundamentals of oncology research, including biostatistics, protocol development, data analysis, medical and research ethics, use and care of animals in research and use of human subjects in research. The majority of the trainee's time is spent conducting research under the direct supervision of a faculty mentor selected by the trainee with additional guidance from the Fellowship Training Program Committee.

Public Health Relevance

In 2009, approximately 1.48 million individuals in the United States will be diagnosed with cancer and 563,000 will die of the disease. Clearly, new approaches to cancer prevention, diagnosis and treatment are needed, and these will only come from new insights achieved through research. This Research Training Program is designed to directly respond to this need by recruiting and training exceptionally qualified physician scientists for a career in cancer research.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Program Officer
Lim, Susan E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Cowan, Andrew J; Inoue, Yoshio; Yu, Evan Y (2015) Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide. Clin Genitourin Cancer 13:e51-3
Shiovitz, Stacey; Bertagnolli, Monica M; Renfro, Lindsay A et al. (2014) CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Gastroenterology 147:637-45
Shiovitz, S; Copeland, W K; Passarelli, M N et al. (2014) Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer. Br J Cancer 111:598-602
Ramos, Jorge D; Cheng, Heather H; Yu, Evan Y (2014) Long-term survival in bone-predominant metastatic urothelial carcinoma. Clin Genitourin Cancer 12:e241-4
Mossanen, Matthew; Lee, Franklin; Cheng, Heather et al. (2014) Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder. Clin Genitourin Cancer 12:210-3
Zimmerman, Zachary F; Kulikauskas, Rima M; Bomsztyk, Karol et al. (2013) Activation of Wnt/*-catenin signaling increases apoptosis in melanoma cells treated with trail. PLoS One 8:e69593
Rezvani, Andrew R; McCune, Jeannine S; Storer, Barry E et al. (2013) Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes. Biol Blood Marrow Transplant 19:1033-9
Cheng, Heather H; Mitchell, Patrick S; Kroh, Evan M et al. (2013) Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLoS One 8:e69239
Marzbani, Edmond; Inatsuka, Carol; Lu, Hailing et al. (2013) The invisible arm of immunity in common cancer chemoprevention agents. Cancer Prev Res (Phila) 6:764-73
Ostronoff, Fabiana; Othus, Megan; Kantarjian, Hagop M et al. (2013) A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia. Br J Haematol 163:130-2

Showing the most recent 10 out of 118 publications